MCT+AE: Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes
Study Details
Study Description
Brief Summary
The aim of this study is to compare the effect on ketone production of dietary an MCT supplement combined or not with physical exercise in two groups of women (N=10/group), healthy adults and patients with prediabetes. After an evaluation of the metabolism (a 4-hour visit with multiple blood samples) at the beginning of the study, all the participants are taken for one-week the MCT supplement alone follow by a one-week period of taking the MCT supplement in combination with physical exercise. At the end of each period of time, the 4-hour visit for the evaluation of the metabolism is repeated.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Healthy women Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. |
Dietary Supplement: MCT
A 5 day consecutive MCT intake of 30 g/day.
Dietary Supplement: MCT+ aerobic exercise
A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days.
Other Names:
Dietary Supplement: Aerobic exercise
A single period of 30 minutes of aerobic exercise (70% to 80% HRR).
Other Names:
Dietary Supplement: Control day
No MCT or aerobic exercise
Other Names:
|
Experimental: Women with prediabetes Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. |
Dietary Supplement: MCT
A 5 day consecutive MCT intake of 30 g/day.
Dietary Supplement: MCT+ aerobic exercise
A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days.
Other Names:
Dietary Supplement: Aerobic exercise
A single period of 30 minutes of aerobic exercise (70% to 80% HRR).
Other Names:
Dietary Supplement: Control day
No MCT or aerobic exercise
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Plasma Ketone Concentrations [5 days]
Acetoacetate (umol/L) and beta-hydroxybutyrate (umol/L); Called Ketones (µmol/L) when combine together The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
Secondary Outcome Measures
- Plasma Glucose Concentrations [5 days]
Glucose (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
- Plasma Triglyceride Concentrations [5 days]
Triglycerides (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
- Plasma Free Fatty Acid Concentrations [5 days]
Free fatty acids (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
- Plasma Insulin Concentrations [5 days]
Insulin (nmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy women group: fasting blood glucose < 6.1 mmol/L and HbA1c < 6.0 %.
-
Women with prediabetes: fasting blood glucose between 6.1 and 6.9 mmol/L and HbA1c between 6.0 and 6.4 %
Exclusion Criteria:
-
Structured physical activity (more than 2 times per week)
-
Inability to practice physical exercise
-
Diabetes (fasting glucose ≥ 7.0mmol/L or HbA1c ≥ 6.5%)
-
Uncontrolled dyslipidemia or hypertension
-
Use of medications known to affect the metabolism of lipids and carbohydrates (steroids, beta-blockers, diuretics, insulin sensitizers, etc.)
-
Severe infections or inflammations
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Research Centre on Aging - CSSS-IUGS - CIUSSS de l'Estrie - CHUS | Sherbrooke | Quebec | Canada | J1H 4C4 |
Sponsors and Collaborators
- Université de Sherbrooke
Investigators
- Principal Investigator: Stephen Cunnane, PhD, Research Centre on Aging, CIUSSS de l'Estrie-CHUS
Study Documents (Full-Text)
More Information
Publications
None provided.- 2015-508
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Period Title: Control (5 Days) | ||
STARTED | 10 | 10 |
COMPLETED | 10 | 10 |
NOT COMPLETED | 0 | 0 |
Period Title: Control (5 Days) | ||
STARTED | 10 | 10 |
COMPLETED | 10 | 10 |
NOT COMPLETED | 0 | 0 |
Period Title: Control (5 Days) | ||
STARTED | 10 | 10 |
COMPLETED | 10 | 9 |
NOT COMPLETED | 0 | 1 |
Period Title: Control (5 Days) | ||
STARTED | 10 | 9 |
COMPLETED | 10 | 9 |
NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Arm/Group Title | Healthy Women | Women With Prediabetes | Total |
---|---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Total of all reporting groups |
Overall Participants | 10 | 9 | 19 |
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
67
(4)
|
68
(5)
|
68
(4)
|
Sex: Female, Male (Count of Participants) | |||
Female |
10
100%
|
9
100%
|
19
100%
|
Male |
0
0%
|
0
0%
|
0
0%
|
Race and Ethnicity Not Collected (Count of Participants) | |||
Count of Participants [Participants] |
0
0%
|
||
Region of Enrollment (participants) [Number] | |||
Canada |
10
100%
|
9
100%
|
19
100%
|
Body mass index (kg/m2) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [kg/m2] |
27
(3)
|
28
(4)
|
27
(4)
|
Total body fat (% of body fat) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [% of body fat] |
43
(6)
|
40
(4)
|
42
(5)
|
Plasma glucose (mmol/L) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [mmol/L] |
5.4
(0.1)
|
6.1
(0.4)
|
5.8
(0.3)
|
Glycated hemoglobin (% of glycated hemoglobin) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [% of glycated hemoglobin] |
5.7
(0.2)
|
6.1
(0.2)
|
5.9
(0.2)
|
Ketones (µmol/L) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [µmol/L] |
153
(94)
|
116
(71)
|
135
(83)
|
Triglycerides (mmol/L) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [mmol/L] |
1.5
(0.4)
|
1.6
(0.8)
|
1.55
(0.6)
|
Free Fatty acids (mmol/L) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [mmol/L] |
0.8
(0.3)
|
0.7
(0.3)
|
0.75
(0.3)
|
Insulin (pmol/L) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [pmol/L] |
64
(11)
|
65
(32)
|
64.5
(22)
|
Outcome Measures
Title | Plasma Ketone Concentrations |
---|---|
Description | Acetoacetate (umol/L) and beta-hydroxybutyrate (umol/L); Called Ketones (µmol/L) when combine together The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11) |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Measure Participants | 10 | 9 |
CTL: AUC ketone |
-52
(117)
|
12
(96)
|
MCT: AUC ketone |
493
(243)
|
627
(489)
|
AE: AUC ketone |
122
(146)
|
23
(74)
|
MCT+AE: AUC ketone |
835
(444)
|
663
(417)
|
Title | Plasma Glucose Concentrations |
---|---|
Description | Glucose (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11) |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Measure Participants | 10 | 9 |
CTL: AUC glucose |
7.6
(1.4)
|
11.0
(2.8)
|
MCT: AUC glucose |
7.3
(1.3)
|
11.6
(2.8)
|
AE: AUC glucose |
7.6
(1.0)
|
10.4
(3.0)
|
MCT+AE: AUC glucose |
7.7
(1.5)
|
10.3
(1.8)
|
Title | Plasma Triglyceride Concentrations |
---|---|
Description | Triglycerides (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11) |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Measure Participants | 10 | 9 |
CTL: AUC triglycerides |
3.6
(0.6)
|
3.8
(0.3)
|
MCT: AUC triglycerides |
3.9
(0.4)
|
3.5
(0.5)
|
AE: AUC triglycerides |
4.0
(0.4)
|
3.7
(0.7)
|
MCT+AE: AUC triglycerides |
3.9
(0.6)
|
3.5
(0.8)
|
Title | Plasma Free Fatty Acid Concentrations |
---|---|
Description | Free fatty acids (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11) |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Measure Participants | 10 | 9 |
CTL: AUC Free fatty acids |
1.3
(0.3)
|
1.3
(0.6)
|
MCT: AUC Free fatty acids |
1.3
(0.2)
|
1.5
(0.4)
|
AE: AUC Free fatty acids |
1.3
(0.2)
|
1.4
(0.3)
|
MCT+AE: AUC Free fatty acids |
1.4
(0.6)
|
1.6
(0.3)
|
Title | Plasma Insulin Concentrations |
---|---|
Description | Insulin (nmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11) |
Time Frame | 5 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Healthy Women | Women With Prediabetes |
---|---|---|
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise |
Measure Participants | 10 | 9 |
CTL: AUC Insulin |
0.9
(0.5)
|
0.8
(0.3)
|
MCT: AUC Insulin |
0.8
(0.3)
|
0.8
(0.8)
|
AE: AUC Insulin |
0.8
(0.2)
|
0.7
(0.3)
|
MCT+AE: AUC Insulin |
0.7
(0.3)
|
0.6
(0.2)
|
Adverse Events
Time Frame | 2 weeks | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Healthy Women | Women With Prediabetes | ||
Arm/Group Description | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise | ||
All Cause Mortality |
||||
Healthy Women | Women With Prediabetes | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/10 (0%) | 0/9 (0%) | ||
Serious Adverse Events |
||||
Healthy Women | Women With Prediabetes | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/10 (0%) | 0/9 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Healthy Women | Women With Prediabetes | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/10 (0%) | 0/9 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Pr. Stephen Cunnane |
---|---|
Organization | Research Centre on Aging |
Phone | 819-780-2220 ext 45670 |
stephen.cunnane@usherbrooke.ca |
- 2015-508